Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Journal of Clinical Hypertension (Greenwich, Conn.)|January 17, 2018
The exaggerated blood pressure response to exercise in the sub-acute phase after stroke is not affected by aerobic exerciseMagnus O Wijkman, Klas Sandberg, Marie Kleist, et al.Journal of Clinical Hypertension (Greenwich, Conn.)|May 2, 2022
Associations between fruit consumption and home blood pressure in a randomly selected sample of the general Swedish populationEdvin Ström, Carl Johan Östgren, Fredrik H Nystrom, et al.Journal of Diabetes and Its Complications|February 1, 2022
Effect of liraglutide on markers of insulin production in persons with type 2 diabetes treated with multiple daily insulin injectionsKlara Westman, Henrik Imberg, Magnus O Wijkman, et al.Journal of Diabetes and Its Complications|April 28, 2021
NT-proBNP versus routine clinical risk factors as a predictor of cardiovascular events or death in people with dysglycemia - A brief report from the ORIGIN trialMagnus O Wijkman, Brian L Claggett, Marc A Pfeffer, et al.Journal of Clinical Hypertension (Greenwich, Conn.)|December 6, 2018
Predictors and correlates of systolic blood pressure reduction with liraglutide treatment in patients with type 2 diabetesMagnus O Wijkman, Mary Dena, Sofia Dahlqvist, et al.Journal of Clinical Hypertension (Greenwich, Conn.)|September 21, 2021
Resistance to antihypertensive treatment and long-term risk: The Atherosclerosis Risk in Communities studyMagnus O Wijkman, Marcus V B Malachias, Brian L Claggett, et al.Diabetes Research and Clinical Practice|November 21, 2022
Importance of NT-proBNP and conventional risk factors for prediction of death in older adults with and without diabetes mellitus- A report from the Atherosclerosis Risk in Communities (ARIC) studyMagnus O Wijkman, Brian L Claggett, Marcus V B Malachias, et al.Hypertension (Dallas, Tex. : 1979)|May 18, 2022
Cardiac Structure and Function Across the Spectrum of Aldosteronism: the Atherosclerosis Risk in Communities StudyJenifer M Brown, Magnus O Wijkman, Brian L Claggett, et al.JAMA Cardiology|March 4, 2026
Spectrum of Primary Aldosteronism and Risk of Cardiovascular Outcomes: The Atherosclerosis Risk in Communities StudyMats C H Lassen, John W Ostrominski, Brian L Claggett, et al.Cardiovascular Diabetology|June 18, 2022
Effects of sacubitril/valsartan on glycemia in patients with diabetes and heart failure: the PARAGON-HF and PARADIGM-HF trialsMagnus O Wijkman, Brian Claggett, Muthiah Vaduganathan, et al.Pageof 2